Building a Better Picture of Cancer
Clinical labs are adopting broader cancer diagnostics—including whole-genome sequencing and multi-omic testing—to deliver more comprehensive molecular insights and improve disease monitoring.
Category: Molecular Diagnostics
Molecular Diagnostics
Latest
Molecular Diagnostics
Latest
Thermo Fisher Highlights New FDA-Cleared Diagnostics at ADLM 2026
The company is showcasing newly cleared tests and platforms for multiple myeloma, lung cancer, connective tissue disease, and other laboratory applications.
Molecular Diagnostics
Latest
Global Study to Evaluate Syndromic PCR Testing for Infectious Diseases
Seegene has launched the Global Million Clinical Study to collect real-world data on the clinical utility of syndromic PCR testing for infectious diseases, aiming to inform future global diagnostic standards.
Caris Life Sciences Launches New Blood Test for Early Cancer Detection
The test utilizes genomic sequencing and AI to identify biological signals associated with early-stage disease.
Read More
Eurobio Scientific Finalizes Acquisition of CareDx Lab Product Division
The transaction includes subsidiaries in the United States, Sweden, and Australia to expand transplantation diagnostic offerings.
Read More
Single-Cell Sequencing May Identify New Exercise Biomarkers
Research suggests new sequencing technologies can help labs move from tissue-level averages to cell-specific testing for precision exercise medicine.
Read More
HerAnova Presents Validation Data for Endometriosis Blood Test
HerAnova Lifesciences presented validation data for HerResolve, a blood-based endometriosis test, showing 94.4% accuracy and detection of cases missed by imaging.
Read More
Roche Launches New DNA Sequencing Platform AXELIOS 1
Roche has launched AXELIOS 1, a single-molecule sequencing platform that uses sequencing by expansion technology to deliver same-day whole-genome results.
Read More
Countable Labs and Promega Partner for Sample Preparation and Rare Variant Detection
The agreement combines extraction and PCR technologies to create an end-to-end workflow for DNA and RNA analysis.
Read More
Watchmaker Genomics Launches Tools to Streamline Sequencing Workflows
The new technologies address library normalization and amplification accuracy for high-throughput and oncology sequencing.
Read More
Myriad Genetics Expands Minimal Residual Disease Testing for Three Cancer Types
The whole-genome sequencing assay is now available for breast, colorectal, and renal cancers following new clinical study results.
Read More
New Clinical Guidelines Recommend Molecular Testing for Bladder Cancer
The NCCN has updated its bladder cancer guidelines to include FDA-approved ctDNA-based MRD testing for post-surgical risk assessment and adjuvant immunotherapy decisions in muscle-invasive bladder cancer.
Read More
FDA Clears Rapid Molecular Test for Group A Strep
The point-of-care assay provides results in 15 minutes and received a waiver for use in decentralized settings.
Read More
AI Reasoning Model Helps Identify Leads for Rare Disease Diagnoses
A study reports that an OpenAI reasoning model improved rare disease diagnostic yield by 4.8% in previously unsolved cases, offering new leads after specialist analysis.
Read More
Study to Evaluate One-Hour Testing for Drug-Resistant Infections
The Fleming Initiative and Cepheid have launched a 30-month study in England to compare rapid molecular and traditional culture screening for drug-resistant carbapenemase-producing Enterobacterales in hospital settings.
Read More
Long-Read Sequencing Improves Diagnosis of Rare Genetic Disorders
A study reports that long-read genome sequencing can replace up to 15 separate tests and improve diagnostic yield for rare genetic disorders, according to researchers in the Netherlands.
Read More
New Guidelines Support CSF Testing for Central Nervous System Cancers
The NCCN has updated its guidelines to recommend cerebrospinal fluid-based molecular profiling for inoperable high-grade gliomas and glioblastomas, expanding indications for liquid biopsy in CNS cancer care.
Read More
Sysmex Europe Launches Automated Blood Testing Platform for Alzheimer’s Disease
The system uses routine blood draws to provide results in 17 minutes, offering an alternative to invasive diagnostic methods.
Read More
- 1
- ...
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
- 41
- 42
- 43
- 44
- 45
- 46
- 47
- 48
- 49
- 50
- 51
- 52
- 53
- 54
- 55
- 56
- 57
- 58
- 59
- 60
- 61
- 62
- 63
- 64
- 65
- 66
- 67
- 68
- 69
- 70
- 71
- 72
- 73
- 74
- 75
- 76
- 77
- 78
- 79
- 80
- 81
- 82
- 83
- 84
- 85
- 86
- 87
- 88
- 89
- 90
- 91
- 92
- 93
- 94
- 95
- 96
- 97
- 98
- 99
- 100
- 101
- 102
- 103
- 104
- 105
- 106
- 107
- ...
- 108